Z3 Capital Partners’s Avidity Biosciences RNAM Stock Holding History

Z3 Capital Partners’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,800	Closed	-$274K	–	197
2025 Q4	$274K	Buy	+3,800	New	+$245K	0.07%	157

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Z3 Capital Partners's RNAM Position: Q1 2026 in Review

Z3 Capital Partners sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,800 shares — an estimated $274K sold.

Z3 Capital Partners first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $274K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Z3 Capital Partners reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Z3 Capital Partners sold 3,800 Avidity Biosciences shares in Q1 2026, an estimated $274K.
Z3 Capital Partners first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Z3 Capital Partners's Avidity Biosciences position peaked at $274K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Z3 Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.